People news: Aveo Pharmaceuticals, Ensemble Therapeutics

Share this article:

Aveo Pharmaceuticals hired Michael Bailey as chief commercial officer, a new position. Bailey joins from Synta Pharmaceuticals, where he has been chief commercial officer since 2008. Prior to Synta, he worked for ImClone, where he led the global launch of targeted cancer therapy Erbitux as head of the biotech's worldwide commercialization organization. Aveo is preparing to ramp up regulatory and commercial planning activities for tivozanib, a triple VEGF inhibitor in Phase III clinical trials for renal cancer.

Biotechnology company Ensemble Therapeutics hired Ted Hibben as SVP for corporate development. Prior to joining Ensemble, Hibben worked as the chief business officer of Cequent Pharmaceuticals and before Cequent he was VP of business development and alliance management at Coley Pharmaceutical Group.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media